ST-segment elevation myocardial infarction (STEMI)

Find all the latest content on STEMI published on this website.

Treating STEMI brings into play a series of clinical and organizational protocols in constant evolution. Today, patients presenting with STEMI are best treated by early reperfusion strategies of which primary PCI is the preferred method. Keep up-to-date on the role of adjunctive pharmacotherapy, advances in imaging techniques and the use of invasive imaging and functional assessment. Tools, devices and techniques as well as complications, such as the different types of vascular access or bleeding risk can be found here as well…

Filtered By
STEMI

516 results

Interactive Case Corner 7 - SVG thrombosis, twisted coronary catheter & stent loss

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn from challenging clinical cases how to manage various complications, such as SVG thrombosis in STEMI, twisted coronary catheter, total stent loss and more!

Interactive Case Corner 7 - SVG thrombosis, twisted coronary catheter & stent loss

How should I treat a chronic total occlusion of the LAD when the conventional hybrid approach fails?

18 Dec 2019

A 54-year-old male was admitted with an inferior ST-segment elevation myocardial infarction. Coronary angiography (CAG) showed a thrombotic occlusion of the RCA and a total chronic occlusion (CTO) of the LAD and PCI on the RCA was performed.

Author

Lars Jakobsen

Author

Evald Christiansen
How should I treat a CTO of the LAD when the conventional hybrid approach fails?

How to treat a patient with challenging STEMI scenarios?

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn how to deal with challenging primary PCI in various STEMI scenarios (LV aneurysm, acute pulmonary embolism...), how to manage unorthodox presentations (such as an arterial lusoria), and how to deal with primary PCI complications (such as a thrombus), thanks to a selection of complex clinical...

How to treat a patient with challenging STEMI scenarios?

Complex and challenging cases I

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn how to manage complex complications, with a selection of challenging clinical cases such as: high-risk left main artery, stent ablation and rota-stenting, LT main lesion, and more!

Complex and challenging cases I

Interactive Case Corner 2 - Rasmussen's aneurysm, recurrent haemoptysis & acute limb ischemia

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to discover a selection of challenging and complex clinical cases, such as rotational atherectomy with distal left radial approach, endovascular management of Rasmussen's aneurysm, recurrent haemoptysis caused by a large pulmonary artery aneurysm, and more!

Interactive Case Corner 2 - Rasmussen's aneurysm, recurrent haemoptysis & acute limb ischemia

Efficacy and safety of low-dose colchicine after myocardial infarction (COLCOT)

09 Dec 2019

COLCOT was a double-blind RCT, designed to evaluate 0.5 mg oral colchicine daily as compared with placebo in patients within 30 days of acute myocardial infarction.

Arturo Giacaman

Reviewer

Arturo Giacaman

Reviewer

Christopher Cook
Efficacy and safety of low-dose colchicine after myocardial infarction

Ticagrelor alone versus dual antiplatelet therapy from 1 month after drug-eluting coronary stenting

10 Nov 2019

One of the most discussed limitations of GLOBAL-LEADER is the lack of event adjudication so that the rate of MI, bleeding or stent thrombosis between the two groups were unknown. In this study, events were adjudicated in those patients from the 20 top-enrolling participating sites.

Reviewer

Salvatore Brugaletta
Ticagrelor alone versus dual antiplatelet therapy from 1 month after drug-eluting coronary stenting

Extensive spontaneous coronary artery dissection in STEMI patient undergoing fibrinolysis

06 Nov 2019

Consult this Twitter Case concerning a 39-year-old female patient with no risk factor for coronary artery disease who presented to the emergency department with anterior STEMI...

Author

Adriano Caixeta
Extensive spontaneous coronary artery dissection in STEMI patient undergoing fibrinolysis

Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?

18 Oct 2019

Over the past year, an abundance of clinical evidence has emerged addressing the conceptually appealing and theoretically justified concept of dropping aspirin, rather than the P2Y12 antagonist, as part of antiplatelet regimens after percutaneous coronary intervention (PCI).

Authors :

M. Tomaniak, R. F. Storey, P. W. Serruys
EuroIntervention: newly-released article on aspirin

ISAR REACT 5 - Ticagrelor versus prasugrel in patients with acute coronary syndrome

03 Sep 2019

At the ESC Congress 2019 in Paris, Stefanie Schuepke presented the results of the ISAR REACT 5 study. Read this analysis by Francesco Costa and view a short interview with Stefanie Schuepke.

Francesco Costa

Author

Francesco Costa
ISAR REACT 5 - Ticagrelor vs prasugrel in patients with acute coronary syndrome